The impact of tacrolimus ointment on health-related quality of life of adult and pediatric patients with atopic dermatitis
- 1 January 2001
- journal article
- clinical trial
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 44 (1), S65-S72
- https://doi.org/10.1067/mjd.2001.109814
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical useBritish Journal of Dermatology, 2010
- Improved Discriminative and Evaluative Capability of a Refined Version of Skindex, a Quality-of-Life Instrument for Patients With Skin DiseasesArchives of Dermatology, 1997
- The effectiveness of acne treatment: an assessment by patients of the outcome of therapyBritish Journal of Dermatology, 1997
- Circulating Skin-Homing T Cells in Atopic DermatitisArchives of Dermatology, 1996
- Cyclosporine in severe childhood atopic dermatitis: A multicenter studyJournal of the American Academy of Dermatology, 1996
- Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical useClinical and Experimental Dermatology, 1994
- Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized, double-blind, placebo-controlled trialBritish Journal of Dermatology, 1993
- Guidelines of care for atopic dermatitisJournal of the American Academy of Dermatology, 1992
- Further studies of scratching during sleepBritish Journal of Dermatology, 1975